Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

L.A. McKeown

April 15, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

Presentation THT 2025

Transcatheter Pulmonary Artery Banding [PAB] for HFrEF: Two Year Follow Up and Invasive Exercise Hemodynamics From the Ongoing First-In-Human Trial

Presenter: Sean Pinney

February 12, 2025

Presentation THT 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 12, 2025

Presentation THT Abstracts 2025

Baroreflex Activation Therapy Improves Cardiopulmonary Exercise Tolerance and Aerobic Capacity in Heart Failure With Reduced Ejection Fraction

Presenter: Dmitry Yaranov

February 11, 2025

Presentation THT Abstracts 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT 2025

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Baroreflex Activation Therapy Improves Cardiopulmonary Exercise Tolerance and Aerobic Capacity in Heart Failure With Reduced Ejection Fraction

Presenter: Dmitry Yaranov

February 11, 2025

Presentation THT 2025

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

Presenter: Takenori Ikoma

February 11, 2025

Presentation THT 2025

How Regulation of Stressed Blood Volume at Rest and Exercise Contributes to HFpEF Symptomatology

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Assessing Determinants of Maximal Exercise Tolerance: What Are the Relative Contributions of PCWP, Ventilatory Anaerobic Threshold and Lactate

Presenter: Yogesh Reddy

February 11, 2025

Presentation THT 2025

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

Presenter: Isabela Landsteiner

February 11, 2025

News Daily News

NT-proBNP Cutoffs for HFpEF Diagnosis May Need Tweaking

Todd Neale

January 29, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

CME

Advertisement

TCTMD’s Top 10 Most Popular Stories for June 2025

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Transcatheter Pulmonary Artery Banding [PAB] for HFrEF: Two Year Follow Up and Invasive Exercise Hemodynamics From the Ongoing First-In-Human Trial

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Baroreflex Activation Therapy Improves Cardiopulmonary Exercise Tolerance and Aerobic Capacity in Heart Failure With Reduced Ejection Fraction

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Baroreflex Activation Therapy Improves Cardiopulmonary Exercise Tolerance and Aerobic Capacity in Heart Failure With Reduced Ejection Fraction

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

How Regulation of Stressed Blood Volume at Rest and Exercise Contributes to HFpEF Symptomatology

Assessing Determinants of Maximal Exercise Tolerance: What Are the Relative Contributions of PCWP, Ventilatory Anaerobic Threshold and Lactate

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

NT-proBNP Cutoffs for HFpEF Diagnosis May Need Tweaking

January 2025 Dispatch for the CV Team

The Role of Atrial Shunts in the Treatment of HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content